Home > D. Systemic pathology > Toxics and drugs > gefitinib
gefitinib
Wednesday 6 June 2007
Gefitinib is an EGFR tyrosine kinase inhibitor.
See also
EGFR mutation-associated NSCLC
Reviews
Herbst RS, Fukuoka M, Baselga J. Gefitinib—a novel targeted approach to treating cancer. Nat Rev Cancer. 2004 Dec;4(12):956-65. PMID: 15573117
References
Gefitinib Yields Superior Outcomes vs Chemotherapy in EGFR-Mutation-Positive NSCLC, Maurie Markman, MD, Medscape, Posted: 06/03/2010
